Assignee
DIRECT BIOLOGICS LLC
US·6 granted patents·8 pending applications·5 citations·filing 2019–2025
Top patents by PatentIndex Score
14 records- 0191US12213995B2Preparations comprising mesenchymal stem cells and cannabinoids and methods of their useDIRECT BIOLOGICS LLC·Filed 2020·Granted Feb 4, 2025·5 cites·8 claims
- 0272US2025186501A1Preparations comprising mesenchymal stem cells and cannabinoids and methods of their useDIRECT BIOLOGICS LLC·Filed 2024·Application pending·0 cites
- 0366US12570980B2Methods and compositions for treating inflammatory conditions associated with infectious diseaseDIRECT BIOLOGICS LLC·Filed 2025·Granted Mar 10, 2026·0 cites·17 claims
- 0466US12502407B2Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesiclesDIRECT BIOLOGICS LLC·Filed 2025·Granted Dec 23, 2025·0 cites·19 claims
- 0566US2025381228A1Method for treating osteoarthritis with mesenchymal stem cell exosomesDIRECT BIOLOGICS LLC·Filed 2025·Application pending·0 cites
- 0662US12590310B2Methods and compositions for treating inflammatory conditions associated with infectious diseaseDIRECT BIOLOGICS LLC·Filed 2021·Granted Mar 31, 2026·0 cites·18 claims
- 0760US12569517B2Method for treating osteoarthritis with mesenchymal stem cell exosomesDIRECT BIOLOGICS LLC·Filed 2020·Granted Mar 10, 2026·0 cites·20 claims
- 0852US2023313191A1Rna comprising secretomes and methods of their useDIRECT BIOLOGICS LLC·Filed 2023·Application pending·0 cites
- 0950US2022079990A1Methods and compositions for treating skin and hair disordersDIRECT BIOLOGICS LLC·Filed 2019·Application pending·0 cites
- 1049US12453743B2Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of useDIRECT BIOLOGICS LLC·Filed 2019·Granted Oct 28, 2025·0 cites·10 claims
- 1149US2022202871A1Method for the treatment of periodontal disease using characterized mesenchymal stem cell growth factors and exosomesDIRECT BIOLOGICS LLC·Filed 2020·Application pending·0 cites
- 1248US2022079987A1Isolation and use of autogenous platelet derived exosomesDIRECT BIOLOGICS LLC·Filed 2020·Application pending·0 cites
- 1346US2022152151A1Acellular intravenous infusion including mesenchymal stem cell growth factors and exosomesDIRECT BIOLOGICS LLC·Filed 2020·Application pending·0 cites
- 1443US2022136053A1Methods and compositions for developing target specific exosome and growth factor productsDIRECT BIOLOGICS LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DIRECT BIOLOGICS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →